Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Plethora Solutions has concluded two agreements to acquire marketing and distribution rights to two prescription medicines (POM), for the treatment of nocturnal enuresis and overactive bladder/urge incontinence (OAB).
Subscribe to our email newsletter
The Urology Company was launched in the second half of 2009 to build a portfolio of approved products to market and distribute into the UK urology market.
With the addition of these two products, Plethora Solutions’ portfolio has attained a critical mass of 8 products, which meets an objective set by the company when establishing The Urology Company in late 2009 to launch between 6 and 9 products during 2010.
Sales of both products are expected to begin in the third quarter of 2010.
Steven Powell, CEO of Plethora Solutions said: “Throughout this first half of 2010 we have continued to build the portfolio of approved products for The Urology Company. We are now focusing our attention on launching these products and building revenues through the second half of the year.”
Plethora Solutions is a specialty pharmaceutical company focused on the development and marketing of products for the treatment of urological disorders